Developing a new drug is an extremely long and expensive journey, often taking more than a decade from discovery to approval. Biological Large Language Models (BioLLMs) are offering new ways to speed up this process by learning the “language” of biology, from DNA and RNA to proteins and small molecules. In this presentation, we’ll explore how, at Loka, we applied these foundation models to deliver value for a biotech client and create measurable impact. We’ll discuss the good, the bad, and the ugly of using BioLLMs in real-world applications, highlighting both their potential and the practical challenges of bringing this technology into production